General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Novartis Corporation(MODEST), Medscape(MODEST), HealthPals(SIGNIFICANT), Movano Health(MODEST), Kento Health(MODEST), Inclusive Health(MODEST), Edwards(MODEST), Arrowhead Pharmaceuticals(MODEST), HeartFlow(MODEST), Cleerly Health(NONE), Amgen Inc.(MODEST) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Carta(NONE) OTHER FINANCIAL BENEFIT: Novo Nordisk Inc.(SIGNIFICANT)
